AJGP Logo
AJGP Logo
  • Article type
    Beyond the clinic door Book review Case Study Clinical Clinical challenge Column Editorial Letters Professional Research Viewpoint
  • Current issue
  • Previous issues
    Academic Post Registrar abstract supplements
     
    WONCA 2023 abstracts
     
    Coronavirus
     
    April 2025 Obesity and weight management March 2025 Psychological medicine January–February 2025 Disaster management December 2024 General practice training and education All issues
     
    Australian Family Physician (AFP)
  • Authors / Reviewers
    Author guidelinesPeer reviewer guidelinesRACGP Clinical guidelinesEditorial Advisory Committee Submit a manuscript
  • About the journal
  • Subscribe to AJGP
  Search
AJGP > Search


Retention rates with monthly depot buprenorphine in general practice in Melbourne, Australia

Retention rates with monthly depot buprenorphine in general practice in Melbourne, Australia

31/05/2022

Depot buprenorphine supported more than half of patients to remain in treatment, while allowing some flexibility in dose interval.


Managing long-term high-dose prescription opioids in patients with non-cancer pain: The potential role of sublingual buprenorphine

Managing long-term high-dose prescription opioids in patients with non-cancer pain: The potential role of sublingual buprenorphine

29/05/2020

Buprenorphine–naloxone is well tolerated by patients with chronic pain, and has the potential to improve pain scores and affective symptoms.


Medicinal cannabis in the treatment of chronic pain

Medicinal cannabis in the treatment of chronic pain

22/09/2021

It is estimated that 600,000 Australians currently self-medicate with cannabis, with chronic pain a leading indication for such use.


The six Rs of managing high-risk opioid prescribing

The six Rs of managing high-risk opioid prescribing

27/02/2020

Patients prescribed high doses of opioids need to be managed appropriately to reduce risks of morbidity and mortality.


General practitioner attitudes towards systems-level opioid prescribing interventions: A pooled secondary qualitative analysis

General practitioner attitudes towards systems-level opioid prescribing interventions: A pooled secondary qualitative analysis

23/04/2021

Beliefs about the usefulness of initiatives to reduce opioid prescribing in clinical practice and autonomy in prescribing may be important considerations in driving compliance.

  • Previous
  • 1
  • Next
Pages: 1 of 1

Australian Journal of General Practice (AJGP) is published by The Royal Australian College of General Practitioners, 100 Wellington Parade, East Melbourne, Victoria 3002, Australia

Email ajgp@racgp.org.au

RACGP Logo

The Royal Australian College of General Practitioners acknowledges Aboriginal and Torres Strait Islander peoples as the Traditional Custodians of the land and sea in which we live and work, we recognise their continuing connection to land, sea and culture and pay our respects to Elders past, present and future.

© 2024 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807